Erythema Multiforme, Stevens–Johnson Syndrome, and Toxic Epidermal Necrolysis

Published on 05/03/2015 by admin

Filed under Dermatology

Last modified 05/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 5199 times

16

Erythema Multiforme, Stevens–Johnson Syndrome, and Toxic Epidermal Necrolysis

Erythema Multiforme

Self-limited, but potentially recurrent, disease.

Two forms: erythema multiforme (EM) major and EM minor (Table 16.1).

Both forms have an abrupt onset of papular ‘target’ lesions that favor acrofacial sites.

Two types of target lesions: (1) typical targets, with at least three different zones; (2) atypical papular targets, with only two different zones and/or a poorly defined border (Fig. 16.1).

EM minor: typical > atypical papular target lesions, little or no mucosal involvement, and no systemic symptoms.

EM major: typical > atypical papular target lesions, moderate to severe mucosal involvement, and some systemic symptoms (fever, asthenia, arthralgia).

Preceding HSV infection is most common precipitating factor; less often other preceding infections, in particular Mycoplasma pneumoniae (Table 16.2; Fig. 16.2); rarely drug exposure.

Diagnosis based on clinicopathologic correlation and not solely histopathologic findings.

EM is a distinct disorder from Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) (see Table 16.1).

EM does not progress to TEN.

DDx: giant urticaria (Fig. 16.3; Table 16.3), morbilliform drug reaction (Fig. 16.4), multiple fixed drug eruption (FDE), acute hemorrhagic edema of infancy, Kawasaki disease, small vessel vasculitis, Rowell’s syndrome, GVHD, polymorphic light eruption (PMLE).

image

Fig. 16.3 

Buy Membership for Dermatology Category to continue reading. Learn more here